Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$1.37M Sell
35,953
-773
-2% -$27.1K ﹤0.01% 1993
2015
Q1
$1.21M Sell
36,726
-12,188
-25% -$374K ﹤0.01% 2054
2014
Q4
$1.31M Sell
48,914
-18,405
-27% -$475K ﹤0.01% 1988
2014
Q3
$1.64M Buy
67,319
+695
+1% +$17.6K ﹤0.01% 1891
2014
Q2
$1.69M Sell
66,624
-65,153
-49% -$1.52M ﹤0.01% 1835
2014
Q1
$2.83M Sell
131,777
-54,696
-29% -$1.18M ﹤0.01% 1596
2013
Q4
$4.17M Sell
186,473
-282,589
-60% -$6.23M 0.01% 1384
2013
Q3
$9.69M Sell
469,062
-164,544
-26% -$3.5M 0.01% 922
2013
Q2
$12.2M Buy
+633,606
New +$13.2M 0.02% 790

Other funds holding HOLX

Managed Account Advisors's HOLX Position: Q2 2015 in Review

Managed Account Advisors reduced its Hologic (HOLX) stake by 2.1% in Q2 2015, selling an estimated $27.1K and leaving 35,953 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Managed Account Advisors first reported a position in HOLX in Q2 2013 and has held it in 9 quarters since. The position peaked at $12.2M in Q2 2013. 395 funds tracked by Wall St. Rank hold HOLX as of Q2 2015.

  • Managed Account Advisors held 35,953 shares of Hologic worth $1.37M as of Q2 2015.
  • Managed Account Advisors sold 773 Hologic shares in Q2 2015, an estimated $27.1K.
  • Hologic made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1993 holding.
  • Managed Account Advisors first reported a position in Hologic in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Hologic position peaked at $12.2M in Q2 2013.
  • 395 funds tracked by Wall St. Rank held Hologic as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.